Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | DGKA | P23743 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.30 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13387963 | 0.84 | MGLL (0.40) | MGLLADRA2AADRA1AMAPTBLM | |
| SCHEMBL9821323 | 0.82 | MGLL (0.41) | MGLLADRA2AADRA1AMAPTBLM | |
| SCHEMBL1406673 | 0.81 | DGKA (0.48) | MAPTDGKATSHR | |
| SCHEMBL1406319 | 0.80 | CYP1A2 (0.45) | GAATSHRCYP4F2CYP4A11 | |
| SCHEMBL1406708 | 0.79 | NAAA (0.55) | DGKATSHR | |
| SCHEMBL1406434 | 0.79 | NAAA (0.55) | DGKATSHR | |
| SCHEMBL3281616 | 0.77 | DGKA (0.43) | MGLLADRA2AADRA1AMAPTBLM | |
| SCHEMBL9821471 | 0.74 | MGLL (0.46) | MGLLADRA2AADRA1AMAPTBLM | |
| SCHEMBL14193599 | 0.74 | MGLL (0.36) | MGLLADRA2AADRA1AMAPTBLM | |
| SCHEMBL475320 | 0.73 | ADRA2A (0.52) | MGLLADRA2AADRA1AMAPTBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1490412-B1 | PHOTOINITIATOR, NOVEL COMPOUND, AND PHOTOCURABLE COMPOSITION | DAINIPPON INK & CHEMICALS (JP) | 2011-03-09 | — | — | EP | disclosed |
| US-7705064-B2 | Photosensitive compounds, photopolymerizable compositions including the same, and methods of making and using the same | HENKEL CORPORATION (US) | 2010-04-27 | — | — | US | disclosed |
| US-7705064-B2 | Photosensitive compounds, photopolymerizable compositions including the same, and methods of making and using the same | HENKEL CORPORATION (US) | 2010-04-27 | — | — | US | disclosed |
| US-20090030106-A1 | Photosensitive Compounds, Photopolymerizable Compositions Including the Same, and Methods of Making and Using the Same | HENKEL CORPORATION (US) | 2009-01-29 | — | — | US | disclosed |
| US-20090030106-A1 | Photosensitive Compounds, Photopolymerizable Compositions Including the Same, and Methods of Making and Using the Same | HENKEL CORPORATION (US) | 2009-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030106-A1 | Photosensitive Compounds, Photopolymerizable Compositions Including the Same, and Methods of Making and Using the Same | PHYKPL, AHCY, ALAD | MGLL 1295/4885ADRA2A 3687/4885ADRA1A 3888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.